Search hospitals > Florida > Miami
University of Miami
Claim this profileMiami, Florida 33136
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for HIV Infection
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
1134 reported clinical trials
182 medical researchers
Summary
University of Miami is a medical facility located in Miami, Florida. This center is recognized for care of Cancer, Breast Cancer, HIV Infection, Lung Cancer, Pancreatic Cancer and other specialties. University of Miami is involved with conducting 1,134 clinical trials across 1,237 conditions. There are 182 research doctors associated with this hospital, such as Julio C Barredo, MD, Jose Lutzky, MD, Danielle Horn, and David Baidal, Dr..Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Julio C Barredo, MDUniversity of Miami Miller School of Medicine-Sylvester Cancer Center8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
46 reported clinical trials
98 drugs studied
Jose Lutzky, MDUniversity of Miami5 years of reported clinical research
Expert in Melanoma
Studies Skin Cancer
20 reported clinical trials
41 drugs studied
Danielle HornUniversity of Miami Don Suffer Clinical Research Building5 years of reported clinical research
Studies Migraine
Studies Osteoarthritis
14 reported clinical trials
12 drugs studied
David Baidal, Dr.Diabetes Research Institute, University of Miami Miller School of Medicine2 years of reported clinical research
Expert in Type 1 Diabetes
Studies Diabetes
13 reported clinical trials
23 drugs studied
Clinical Trials running at University of Miami
Breast Cancer
Non-Hodgkin's Lymphoma
Parkinson's Disease
Cancer
Lymphoma
Multiple Myeloma
B-Cell Lymphoma
Depression
Colorectal Cancer
Stomach Cancer
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
Farletuzumab Ecteribulin
for Solid Cancers
The primary objectives of the study are: (1) in the dose-escalation part: to evaluate safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of farletuzumab ecteribulin (MORAb-202) in participants with selected tumor types (ovarian cancer \[OC\], endometrial cancer \[EC\], non-small cell lung carcinoma \[NSCLC\], triple-negative breast cancer \[TNBC\]), and (2) in dose-confirmation part: to evaluate preliminary efficacy measured by objective response rate (ORR) of farletuzumab ecteribulin (MORAb-202) in participants with OC and EC at selected doses and to further evaluate the safety and tolerability of farletuzumab ecteribulin (MORAb-202) and (3) dose-optimization part. (divided in two parts: Part A \[OC and EC participants\] and Part B \[OC only\]): Part A: to evaluate other farletuzumab ecteribulin (MORAb-202) treatment regimens for safety, tolerability and preliminary efficacy in participants with OC and EC; to evaluate the addition of short course of oral corticosteroids following every dose of farletuzumab ecteribulin (MORAb-202) administered every 21 days; and to select treatment regimens with farletuzumab ecteribulin (MORAb-202) for further evaluation in Part B. Part B: to evaluate the safety and tolerability of different doses of farletuzumab ecteribulin (MORAb-202) as monotherapy and in combination with lenvatinib and to determine the recommended dose (RD) of farletuzumab ecteribulin (MORAb-202) as monotherapy and in combination with lenvatinib.
Recruiting1 award Phase 1 & 2
IAM1363
for Breast Cancer
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Miami?
University of Miami is a medical facility located in Miami, Florida. This center is recognized for care of Cancer, Breast Cancer, HIV Infection, Lung Cancer, Pancreatic Cancer and other specialties. University of Miami is involved with conducting 1,134 clinical trials across 1,237 conditions. There are 182 research doctors associated with this hospital, such as Julio C Barredo, MD, Jose Lutzky, MD, Danielle Horn, and David Baidal, Dr..
Where is University of Miami located?
To reach the University of Miami Hospital, from I-95 take S.R. 836 West, exit at N.W. 12th Avenue and proceed north to the medical center complex at N.W. 16th Street. Alternatively, from S.R. 836 East, exit at N.W. 17th Avenue North, turn right onto N.W. 17th Avenue, right at N.W. North River Drive, left at N.W. 13th Terrace, right onto N.W. 14th Street, and continue to N.W. 12th Avenue.
Who should I call to ask about financial aid or insurance network?
For financial assistance at the University of Miami Hospital, visit the Office of Student Financial Assistance and Employment located at 1306 Stanford Drive, Suite 1210, Coral Gables, FL 33146, or call 305-284-3004. UHealth has appointed Aetna as its primary behavioral health administrator for insurance-related inquiries. International patients can benefit from bundled package pricing for self-pay options and insurance coverage verification for insured patients.
What insurance does University of Miami accept?
The University of Miami Hospital accepts a wide range of insurance plans, including but not limited to Aetna Medicare (HMO/PPO), Aetna Medicaid (HMO), AvMed Medicare (HMO), and BCBS of FL (excluding SELECT Plans). It also contracts with several managed health organizations, such as Freedom Health Medicare (HMO), Humana Medicare (HMO), and Solis Health Plans. Furthermore, all indemnity insurance products, Champus, Workers Compensation, Medicare, and Medicaid are accepted at the University of Miami Health System hospitals and clinics.
What awards or recognition has University of Miami received?
The University of Miami Hospital, located in Miami, Florida, is renowned for its exceptional staffing practices, earning the title of the top health care brand in the nation for employment. Furthermore, the University of Miami Miller School of Medicine has been awarded over $175 million in funding from the National Institutes of Health, marking the highest amount in its history, dedicated to research and care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.